A section of patients have exhibited multi-organ damage [148,149,150]; notably, liver damage has emerged as a co-existing symptom, as observed in a recent epidemiological study carried out in Shanghai (China), where 75 of 148 COVID-19 patients had abnormal liver functioning evident by higher amounts of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bilirubin (TBIL) [151]. Here, GPT is linked to COVID-19.